Robbins Arroyo LLP Is Investigating the Officers and Directors of Nu Skin Enterprises, Inc. (NUS) on Behalf of Shareholders

Loading...
Loading...

SAN DIEGO and PROVO, Utah, July 1, 2015 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Nu Skin Enterprises, Inc. NUS breached their fiduciary duties to shareholders.  Nu Skin develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex brands worldwide.

View this press release on the law firm's Shareholder Rights Blog: http://www.robbinsarroyo.com/shareholders-rights-blog/nu-skin-enterprises-inc-july-2015

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, DDonahue@robbinsarroyo.com, or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.  For more information, please go to www.robbinsarroyo.com.  

Attorney Advertising. Past results do not guarantee a similar outcome.  

Contact:
Darnell R. Donahue
Robbins Arroyo LLP
DDonahue@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36754LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/robbins-arroyo-llp-is-investigating-the-officers-and-directors-of-nu-skin-enterprises-inc-nus-on-behalf-of-shareholders-300107750.html

SOURCE Robbins Arroyo LLP

Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...